DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

Raymond James Downgrades Gilead Sciences to Outperform, Lowers Price Target to $80

Raymond James analyst Steven Seedhouse downgrades Gilead Sciences (NASDAQ:GILD) from Strong Buy to Outperform and lowers the price target from $81 to $80.

Benzinga · 02/05/2020 10:14

Raymond James analyst Steven Seedhouse downgrades Gilead Sciences (NASDAQ:GILD) from Strong Buy to Outperform and lowers the price target from $81 to $80.